I would advise doing some research into adverse effects of the experimental mRNA gene therapy. The yellow card system is a start:
https://yellowcard.mhra.gov.uk/ but a better front end to that information, which is easily searchable is at:
https://yellowcard.ukcolumn.org/yellow-card-reports . Many doctor groups have called for a halt.
https://www.mdpi.com/2076-393X/9/7/693/htm
The present assessment raises the question whether it would be necessary to rethink policies and use COVID-19 vaccines more sparingly and with some discretion only in those that are willing to accept the risk because they feel more at risk from the true infection than the mock infection. Perhaps it might be necessary to dampen the enthusiasm by sober facts? In our view, the EMA and national authorities should instigate a safety review into the safety database of COVID-19 vaccines and governments should carefully consider their policies in light of these data. Ideally, independent scientists should carry out thorough case reviews of the very severe cases, so that there can be evidence-based recommendations on who is likely to benefit from a SARS-CoV2 vaccination and who is in danger of suffering from side effects. Currently, our estimates show that we have to accept four fatal and 16 serious side effects per 100,000 vaccinations in order to save the lives of 2–11 individuals per 100,000 vaccinations, placing risks and benefits on the same order of magnitude.
-----------------------------------
By Malone inventor of mRNA technology
https://trialsitenews.com/bioethics-...ts-going-down/
-----------------------------------
https://www.crick.ac.uk/news/2021-06...d-in-indiaThey found that in people who had been fully vaccinated with two doses of the Pfizer-BioNTech vaccine, levels of neutralising antibodies were more than five times lower* against the B.1.617.2 variant when compared to the original strain, upon which current vaccines are based.
Importantly, this antibody response was even lower in people who had only received one dose. After a single dose of Pfizer-BioNTech, 79% of people had a quantifiable neutralising antibody response against the original strain, but this fell to 50% for B.1.1.7, 32% for B.1.617.2 and 25% for B.1.351.
-------------------------
Class action in progress
https://www.bitchute.com/video/tmSpGjVV1lsl/